← Eichor
Study identifier: NCT07156058 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

MiniPDX-based Postoperative Adjuvant Therapy for Biliary Tract Cancer

Condition: Biliary Tract Cancer  ·  Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences

PhaseNA
Planned participants204
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This research aims to study the effect of postoperative adjuvant therapy with a MiniPDX drug sensitivity test for biliary tract cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Xinyu Bi, M.D.  ·  13911792177  ·  beexy1971@163.com

Always discuss trial participation with your own doctor first.

Locations (1)

Cancer Institute and Hospital, Chinese Academy of Medical SciencesBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07156058